Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
1.802 EUR | +0.11% | +9.34% | -32.26% |
Apr. 08 | Advicenne S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Mar. 25 | Advicenne: ODD designation in cystinuria | CF |
Sales 2024 * | 4.2M 4.53M | Sales 2025 * | 5.75M 6.2M | Capitalization | 22.11M 23.85M |
---|---|---|---|---|---|
Net income 2024 * | -7M -7.55M | Net income 2025 * | 22M 23.74M | EV / Sales 2024 * | 10.7 x |
Net Debt 2024 * | 22.7M 24.49M | Net cash position 2025 * | 3.2M 3.45M | EV / Sales 2025 * | 3.29 x |
P/E ratio 2024 * |
-2.81
x | P/E ratio 2025 * |
0.87
x | Employees | 21 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 88.22% |
1 day | +0.11% | ||
1 week | +9.34% | ||
Current month | +11.93% | ||
1 month | +12.62% | ||
3 months | +10.55% | ||
6 months | -7.11% | ||
Current year | -32.26% |
Managers | Title | Age | Since |
---|---|---|---|
Didier Laurens
CEO | Chief Executive Officer | 59 | 21-05-02 |
Chief Tech/Sci/R&D Officer | - | 23-03-31 | |
André Ulmann
BRD | Director/Board Member | - | 17-06-22 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | - | 11-04-28 | |
Catherine Dunand
BRD | Director/Board Member | 62 | 17-03-08 |
Didier Laurens
CEO | Chief Executive Officer | 59 | 21-05-02 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 1.802 | +0.11% | 23 595 |
24-05-09 | 1.8 | +5.76% | 49,918 |
24-05-08 | 1.702 | +1.79% | 29,436 |
24-05-07 | 1.672 | -2.79% | 15,190 |
24-05-06 | 1.72 | +4.37% | 16,244 |
Real-time Euronext Paris, May 10, 2024 at 09:52 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-32.26% | 23.82M | |
-2.61% | 88.47B | |
+3.55% | 40.71B | |
-13.94% | 32.43B | |
+55.77% | 24.28B | |
-15.01% | 15.52B | |
-41.29% | 12.17B | |
-14.92% | 12.01B | |
-11.75% | 12B | |
+7.42% | 8.87B |
- Stock Market
- Equities
- ALDVI Stock